U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Previous Screen

Ketorolac Tromethamine Injection
Status: Currently in Shortage
»Date first posted: 03/23/2018
»Therapeutic Categories: Analgesia/Addiction

Expand all

Baxter Healthcare (Reverified 07/01/2022)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ketorolac Tromethamine Injection, USP, 30 mg/ mL. Single dose glass flip top vial - 25 units per carton (NDC 0338-0072-25) Available
Ketorolac Tromethamine Injection, USP, 15 mg/mL. Single dose glass flip top vial. 10 units per carton (NDC 0338-0069-10) Available

Fresenius Kabi USA, LLC (Revised 08/12/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
15 mg per mL, Single Dose, Simplist Syringe, (NDC 76045-107-10) Backordered. Next release not available at this time.
30 mg per mL, Single Dose, Simplist Syringe, (NDC 76045-104-10) Available
60 mg per 2 mL, Single Dose, Simplist Syringe, (NDC 76045-105-20) 1 month expiry (9/2022 expiry) dating available by request.
15 mg per mL, Single Dose Amber Vial, (NDC 63323-161-01) Available Manufacturing delays
30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-01) Available Manufacturing delays
30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-02) Backordered. Next release August 2022. Manufacturing delays

Gland Pharma Limited (Reverified 08/12/2022)

Company Contact Information:
855-273-0154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
15 mg/mL vial (NDC 70860-700-01 and 70860-700-02) Available Demand increase for the drug
30 mg/mL vial (NDC 70860-701-01 and 70860-701-03) Available Demand increase for the drug
60 mg/mL vial (NDC 70860-701-02 and 70860-701-04) Available Demand increase for the drug
30 mg/mL, 1 mL vial (NDC 72266-118-25) Available Demand increase for the drug
30 mg/mL, 2 mL vial (NDC 72266-119-25) Available Available

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Reverified 04/08/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
15 mg/mL, 1 mL vial (NDC 0641-6041-25) Unavailable, shortage recovery TBD. Demand increase for the drug
30 mg/mL, 1 mL vial (NDC 0641-6042-25) Unavailable, shortage recovery TBD. Demand increase for the drug
30 mg/mL, 2 mL vial (NDC 0641-6043-25) Unavailable, shortage recovery TBD. Demand increase for the drug

Hospira, Inc. (Reverified 07/01/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
30 mg/mL (30 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-2287-23) Discontinued Discontinuation of the manufacture of the drug
30 mg/mL (30 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2287-31) Discontinued Discontinuation of the manufacture of the drug
60 mg/2 mL (30 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2287-61) Discontinued Discontinuation of the manufacture of the drug
15 mg/mL (15 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3793-01) Limited Supply Available. Next Delivery: June 2022; Estimated Recovery: January 2023 Demand increase for the drug
30 mg/mL (30 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3795-01) Next Delivery: June 2022; Estimated Recovery: November 2022 Demand increase for the drug
60 mg/2 mL (30 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3796-01) Limited Supply Available. Next Delivery: June 2022; Estimated Recovery: January 2023 Demand increase for the drug

Sagent Pharmaceuticals (Reverified 08/12/2022)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
KETOROLAC TROMETHAMINE INJECTION 15MG/ML 25X1ML (NDC 25021-700-01) Backordered. Estimated availability TBD Manufacturing delays
KETOROLAC TROMETHAMINE INJECTION 30MG/ML 25X2ML (NDC 25021-701-02) Backordered. Estimated availability TBD Manufacturing delay
KETOROLAC TROMETHAMINE INJECTION 30MG/ML 25X1ML (NDC 25021-701-01) Backordered. Estimated availability TBD Manufacturing delay

Virtus Pharmaceuticals (New 03/26/2018)

Company Contact Information:
888-843-3593

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
30MG/ML (NDC 69543-0386-25) Available Other
Back to Top